InfuSystem sees FY25 revenue growth 8%-10%, consensus $147.89M

“InfuSystem (INFU) is providing annual guidance for the full year 2025 with net revenue growth estimated to be in the 8% to 10% range. We are also forecasting adjusted EBITDA margin to be in the high-teens, exceeding the company’s margin of 18.8% in 2024, this despite the planned continued investment in the company’s information technology systems. The company intends to update its annual guidance throughout the year.”